Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Compare retirement index funds to see which has the lowest fees while meeting your risk and diversification goals.
28,038 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Elon Musk and Senator Bernie Sanders clash over how to tax the ultrawealthy, using the same math to argue for opposit...
Bitcoin steadies near $72,800 as ETF inflows push a relief bounce, with traders citing liquidity gains and hedging de...
Bitcoin sits roughly 43% below its all-time high as macro headwinds and fund outflows weigh on sentiment. This report...
A major stake move by Arnhold LLC in Kyndryl Holdings has turned heads. This article breaks down what the purchase me...
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
Plug Power aims to become profitable by 2028. This article breaks down the plan, the main risks, and concrete steps i...
Runlayer closed a $30 million Series A led by FELICIS with Khosla Ventures joining, bringing total funding to $42 mil...
The IMF says the U.S. economy remains robust, but mounting deficits and tariff policy threaten long-term balance. Thi...
AI-driven infrastructure growth is lifting semiconductor ETFs and a broad set of chipmakers. The wave is broadening b...
The dramatic shift policy just signaled by the Fed has set the stage for a new era in healthcare investing. Bristol M...
Traders chase BOIL as natural gas whipsaws drive outsized moves, despite heavy losses over the past year. The 2x leve...